Considering his personal (a second cancer diagnosis – arm sarcoma) and family history, an additional genetic analysis was proposed in 2022 in order to search for mutations in other genes, in particular on POT1 whose spectrum could correspond to the history of cancers reported and was included in our oncogenetic gene panel. This evidence concerns the gene POT1 and cancer.